Hyperbaric Oxygen Therapy (HBOT) for Autism: An Introduction
This article focuses on a doctor whose chose to put his son with Autism into a retrospective HBOT study.
The doctor found improvement in language, sociability, GI function, and cognition.
This improvement is due to an increase in blood flow in the brain and reduces inflammation.
Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism
This article looks are a variety of symptoms associated with autism, and how HBOT assisted in the treatment of these symptoms.
The study looked at cerebral hypoperfusion, neuroinflammation, gastrointestinal inflammation, immune function, oxidative stress, mitochondrial dysfunction, neurotransmitter abnormalities, toxin exposure, dysbiosis, porphyrin production, and stem cells.
Hyperbaric Oxygen Therapy in Thai Autistic Children
This article discusses a scientific study involving 7 Thai children with autism who received hyperbaric oxygen therapy.
75% of the children had improvements in social development, fine motor and eye-hand coordination, language development, gross motor development, and self-help skills.
This short article focuses on how HBOT therapy helped Ian, a child with autism, gain more control of his body and life.
In this article, doctors treated nine adults with toxic encephalopathy, and two children, one with toxic encephalopathy and the other with autism.
Patients underwent HBOT for 10 day, for one hour each time.
HBOT lead to significant improvements in the patients, without side effects.
Additionally, the article shows brain scans of the progress HBOT made.
This longer article focus on how oxygenating the brain through HBOT allows children with autism to have improved function.
The improved function is achieved through reducing neuroinflammation, oxidative stress, and stem cell mobilization.
To test improvement levels, researchers used the Autism Treatment Evaluation Checklist (ATEC), Childhood Autism Rating Scale (CARS), and Social Responsiveness Scale (SRS).
The results found that HBOT was well tolerated by all 6 children with no side effects. More dramatic improvements were found in children age 4 and under when compared to those in the older group.
